Evidence map›Paper›PMID 32113662›Full record

ArticleThe American journal of pathology2020

Haploinsufficiency of Casitas B-Lineage Lymphoma Augments the Progression of Colon Cancer in the Background of Adenomatous Polyposis Coli Inactivation.

Sean Richards, Joshua Walker, Masako Nakanishi, Mostafa Belghasem, Chimera Lyle, Nkiruka Arinze, Marc A Napoleon, Jonathan D Ravid, Nicholas Crossland, Qing Zhao and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Sean RichardsDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts.
Joshua WalkerDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts.
Masako NakanishiCenter for Molecular Oncology, University of Connecticut Health Center, Farmington, Connecticut.
Mostafa BelghasemDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts.
Chimera LyleDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts.
Nkiruka ArinzeDepartment of Surgery, Boston University School of Medicine, Boston, Massachusetts.
Marc A NapoleonDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts.
Jonathan D RavidSchool of Medicine, Boston University, Boston, Massachusetts.
Nicholas CrosslandDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts.
Qing ZhaoDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts.
Daniel RosenbergCenter for Molecular Oncology, University of Connecticut Health Center, Farmington, Connecticut.
Nader RahimiDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts.
Vipul C ChitaliaDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts; Veterans Affairs Boston Healthcare System, Boston, Massachusetts; Global Co-Creation Labs, Institute of Medical Engineering and Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts. Electronic address: vichital@bu.edu.
Boston University · USMolecular Oncology (United States) · USVA Boston Healthcare System · US

Funding

Multidisciplinary Training in Cardiovascular ResearchT32HL007224 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HAMBURG, NAOMI MIRIAM, WAINFORD, RICHARD DAVID · 1985 to 2020
$12.3M
RESEARCH TRAINING IN NEPHROLOGYT32DK007053 · NIDDK · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RIFKIN, IAN R · 1986 to 2019
$3.9M
Impact of Biological, Clinical, and Social Determinants on Trauma and Trauma OutcomesT32GM086308 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Alik Farber, Daniel G. Remick · 2010 to 2026
$3.5M
Role of c-Cbl in Colon cancerR01CA175382 · NCI · BOSTON MEDICAL CENTER · PI CHITALIA, VIPUL C · 2014 to 2018
$1.8M
Thrombotic complication of uremia: role of prothrombotic uremic solutesR01HL132325 · NHLBI · BOSTON MEDICAL CENTER · PI CHITALIA, VIPUL C · 2016 to 2019
$1.7M
IGPR-1 in colon cancer chemotherapyR21CA193958 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RAHIMI, NADER · 2015 to 2016
$392k
Overcoming the resistance to anti-angiogenesis therapyR21CA191970 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RAHIMI, NADER · 2015 to 2016
$392k
NCI NIH HHS R01 CA175382NCI NIH HHS R21 CA191970NCI NIH HHS R21 CA193958NHLBI NIH HHS R01 HL132325NHLBI NIH HHS T32 HL007224NIDDK NIH HHS T32 DK007053NIGMS NIH HHS T32 GM086308
6 · The paper itself

Abstract

Casitas B-lineage lymphoma (c-Cbl) is a recently identified ubiquitin ligase of nuclear β-catenin and a suppressor of colorectal cancer (CRC) growth in cell culture and mouse tumor xenografts. We hypothesized that reduction in c-Cbl in colonic epithelium is likely to increase the levels of nuclear β-catenin in the intestinal crypt, augmenting CRC tumorigenesis in an adenomatous polyposis coli (APC

Indexed as

HaploinsufficiencyAdenocarcinomaAdenomatous Polyposis Coli ProteinAnimalsbeta CateninCarcinogenesisColonic NeoplasmsColorectal NeoplasmsDisease ProgressionFemaleGene Expression Regulation, NeoplasticLymphomaMaleMiceMice, Inbred C57BLProto-Oncogene Proteins c-cblAdenomatous Polyposis Coli Proteinadenomatous polyposis coli protein, mousebeta CateninCbl protein, mouseCTNNB1 protein, mouseProto-Oncogene Proteins c-cblWnt Proteins

Identifiers

PMID32113662
PMCPMC7074366
OpenAlexW3010414127

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.